Cargando…
The inhibitory effect of melatonin on human prostate cancer
Prostate cancer (PCa) is one of the most commonly diagnosed human cancers in males. Nearly 191,930 new cases and 33,330 new deaths of PCa are estimated in 2020. Androgen and androgen receptor pathways played essential roles in the pathogenesis of PCa. Androgen depletion therapy is the most used ther...
Autores principales: | Shen, Dexin, Ju, Lingao, Zhou, Fenfang, Yu, Mengxue, Ma, Haoli, Zhang, Yi, Liu, Tongzu, Xiao, Yu, Wang, Xinghuan, Qian, Kaiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962396/ https://www.ncbi.nlm.nih.gov/pubmed/33722247 http://dx.doi.org/10.1186/s12964-021-00723-0 |
Ejemplares similares
-
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
por: Shen, Dexin, et al.
Publicado: (2023) -
The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021) -
E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability
por: Xu, Huimin, et al.
Publicado: (2021) -
Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways
por: Deng, Zhao, et al.
Publicado: (2023) -
The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer
por: Xiong, Kangping, et al.
Publicado: (2021)